FI861262A - 5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ. - Google Patents

5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ. Download PDF

Info

Publication number
FI861262A
FI861262A FI861262A FI861262A FI861262A FI 861262 A FI861262 A FI 861262A FI 861262 A FI861262 A FI 861262A FI 861262 A FI861262 A FI 861262A FI 861262 A FI861262 A FI 861262A
Authority
FI
Finland
Prior art keywords
sup
group
hydrogen atom
represents hydrogen
lower alkyl
Prior art date
Application number
FI861262A
Other languages
English (en)
Other versions
FI86722C (fi
FI861262A0 (fi
FI86722B (fi
Inventor
Motosuke Yamanaka
Kazutoshi Miyake
Shinji Suda
Hideto Ohhara
Toshiaki Ogawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of FI861262A0 publication Critical patent/FI861262A0/fi
Publication of FI861262A publication Critical patent/FI861262A/fi
Priority to FI921298A priority Critical patent/FI91758C/fi
Application granted granted Critical
Publication of FI86722B publication Critical patent/FI86722B/fi
Publication of FI86722C publication Critical patent/FI86722C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI861262A 1985-03-26 1986-03-25 Foerfarande foer framstaellning av som laekemedel anvaendbart 5-(6-imidatso/1,2-a/pyridyl)pyridinderivat FI86722C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI921298A FI91758C (fi) 1985-03-26 1992-03-25 Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60059450A JPS61218589A (ja) 1985-03-26 1985-03-26 ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
JP5945085 1985-03-26

Publications (4)

Publication Number Publication Date
FI861262A0 FI861262A0 (fi) 1986-03-25
FI861262A true FI861262A (fi) 1986-09-27
FI86722B FI86722B (fi) 1992-06-30
FI86722C FI86722C (fi) 1992-10-12

Family

ID=13113637

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861262A FI86722C (fi) 1985-03-26 1986-03-25 Foerfarande foer framstaellning av som laekemedel anvaendbart 5-(6-imidatso/1,2-a/pyridyl)pyridinderivat

Country Status (23)

Country Link
US (4) US4751227A (fi)
EP (1) EP0199127B1 (fi)
JP (1) JPS61218589A (fi)
KR (1) KR930005005B1 (fi)
CN (1) CN1020608C (fi)
AT (1) ATE48603T1 (fi)
AU (1) AU589410B2 (fi)
CA (1) CA1309718C (fi)
DD (2) DD263057A5 (fi)
DE (1) DE3667466D1 (fi)
DK (1) DK164788C (fi)
ES (5) ES8706146A1 (fi)
FI (1) FI86722C (fi)
GR (1) GR860720B (fi)
HU (1) HU198045B (fi)
IE (1) IE59294B1 (fi)
IL (1) IL78248A (fi)
MX (1) MX163696B (fi)
NO (1) NO163490C (fi)
PH (1) PH22999A (fi)
PT (1) PT82270B (fi)
SU (1) SU1468420A3 (fi)
ZA (1) ZA862259B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
CA2060309A1 (en) * 1989-06-13 1990-12-14 Alison M. Badger Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2010331175B2 (en) * 2009-12-18 2014-08-28 Mitsubishi Tanabe Pharma Corporation Novel antiplatelet agent
CN101830900B (zh) * 2010-05-27 2012-06-06 齐鲁制药(海南)有限公司 盐酸奥普力农晶型及其制备方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
CN102702197B (zh) * 2012-06-27 2014-12-03 武汉武药科技有限公司 盐酸奥普力农衍生物及其制备方法
CN102718747B (zh) * 2012-06-27 2014-06-11 武汉武药科技有限公司 盐酸奥普力农衍生物及其合成方法
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX2016001714A (es) 2013-08-09 2016-10-03 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
CN106349246B (zh) * 2016-08-29 2018-10-26 山东百诺医药股份有限公司 奥普力农及9-氮杂吲哚-5-硼酸的制备方法
CN108840866A (zh) * 2018-05-24 2018-11-20 河北宇辰医药科技有限公司 一种奥普力农类似物ⅰ的制备方法与用途
CN109575017A (zh) * 2018-11-01 2019-04-05 山东蒲济医药科技有限公司 一种盐酸奥普力农化合物的制备方法
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN111499631B (zh) * 2020-06-02 2021-07-30 济南康桥医药科技有限公司 一种盐酸奥普力农关键中间体1-咪唑并[1,2-a]吡啶-6-基-2-丙酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
EP0199127A1 (en) 1986-10-29
GR860720B (en) 1986-03-25
ES553370A0 (es) 1987-05-16
FI86722C (fi) 1992-10-12
DD283390A5 (de) 1990-10-10
IL78248A0 (en) 1986-07-31
ES8708230A1 (es) 1987-10-01
AU589410B2 (en) 1989-10-12
ES8801654A1 (es) 1988-02-16
EP0199127B1 (en) 1989-12-13
FI861262A0 (fi) 1986-03-25
DE3667466D1 (de) 1990-01-18
CA1309718C (en) 1992-11-03
DD263057A5 (de) 1988-12-21
FI86722B (fi) 1992-06-30
MX163696B (es) 1992-06-15
AU5507286A (en) 1986-10-02
ES557587A0 (es) 1988-02-16
ES557236A0 (es) 1987-10-01
JPH0558437B2 (fi) 1993-08-26
ZA862259B (en) 1986-11-26
PT82270B (pt) 1988-02-17
NO163490C (no) 1990-06-06
ES8708231A1 (es) 1987-10-01
NO861190L (no) 1986-09-29
US4803276A (en) 1989-02-07
DK164788B (da) 1992-08-17
ES557588A0 (es) 1988-02-16
ES8706146A1 (es) 1987-05-16
IE59294B1 (en) 1994-02-09
SU1468420A3 (ru) 1989-03-23
PH22999A (en) 1989-02-24
KR860007257A (ko) 1986-10-10
US4751227A (en) 1988-06-14
IL78248A (en) 1989-09-10
US4791203A (en) 1988-12-13
ATE48603T1 (de) 1989-12-15
ES8801655A1 (es) 1988-02-16
DK137786A (da) 1986-09-27
CN86102812A (zh) 1986-11-26
PT82270A (en) 1986-04-01
NO163490B (no) 1990-02-26
KR930005005B1 (ko) 1993-06-11
DK164788C (da) 1992-12-28
JPS61218589A (ja) 1986-09-29
CN1020608C (zh) 1993-05-12
DK137786D0 (da) 1986-03-25
HU198045B (en) 1989-07-28
ES557235A0 (es) 1987-10-01
IE860775L (en) 1986-09-26
HUT41026A (en) 1987-03-30
US4791202A (en) 1988-12-13

Similar Documents

Publication Publication Date Title
FI861262A (fi) 5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ.
EP0383449A3 (en) Pyridazinone derivatives and processes for preparing the same
DK160098C (da) Tricycliske oxindolcarboxamid-derivater
SE8300580D0 (sv) Substituerade 1,3,4-tiadiazolo (3,2-a)pyrimidiner och forfarande for deras framstellning
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: EISAI CO., LTD.

MA Patent expired